Condemning the pro-abortion policies of the Biden administration.

This resolution (HRES 1285) is a symbolic statement by a group of House members condemning the Biden administration's approach to mifepristone (the abortion pill), specifically the 2023 FDA decision allowing mail-order and pharmacy dispensing of the drug without in-person provider visits. It argues this policy eliminates safety safeguards like in-person ultrasounds to detect ectopic pregnancies, gestational age checks, and provider screening for coercion, potentially increasing health risks for patients. The resolution does not change any laws or policies but expresses disapproval of the FDA’s regulatory changes regarding mifepristone distribution. As a non-binding resolution, it has no legal effect on abortion access or drug regulations.